Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hyperphosphatemia in Chronic Kidney Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02965053
What this trial is testing

A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis

Who this might be right for
Hyperphosphatemia
Chugai Pharmaceutical 26
Large-scale testing (Phase 3)Ended earlyNCT01814904
What this trial is testing

Dose-finding Study of MCI-196

Who this might be right for
Chronic Kidney DiseaseDialysisHyperphosphatemia+1 more
Tanabe Pharma Corporation 10
Large-scale testing (Phase 3)Study completedNCT07030595
What this trial is testing

AP301 Efficacy and Safety in Chinese Dialysis Patients With Hyperphosphatemia

Who this might be right for
ESRD (End Stage Renal Disease)Chronic Kidney Disease(CKD)Hyperphosphatemia+3 more
Alebund Pharmaceuticals 474
Testing effectiveness (Phase 2)Study completedNCT00704678
What this trial is testing

Optimal Titration Regimen for SBR759 in Lowering Serum Phosphate Levels in Asian Chronic Kidney Disease Patients on Hemodialysis

Who this might be right for
Chronic Kidney Disease
Novartis Pharmaceuticals 203
Not applicableStudy completedNCT01116947
What this trial is testing

Fosrenol for Enhancing Dietary Protein Intake in Hypoalbuminemic Dialysis Patients (FrEDI) Study

Who this might be right for
End-Stage Renal Disease
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center 108
Large-scale testing (Phase 3)Study completedNCT01742585
What this trial is testing

ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis

Who this might be right for
Chronic Kidney DiseaseRenal InsufficiencyHyperphosphatemia
Astellas Pharma Inc 163
Post-approval studies (Phase 4)Study completedNCT02209636
What this trial is testing

Phosphate Lowering in CKD Trial

Who this might be right for
Chronic Kidney DiseaseCardiovascular Disease
VA Office of Research and Development 66
Large-scale testing (Phase 3)Study completedNCT01069692
What this trial is testing

Placebo Versus SBR759 in Lowering Phosphate in Dialysis Patients

Who this might be right for
HyperphosphatemiaChronic Kidney Disease
Novartis 115
Large-scale testing (Phase 3)Ended earlyNCT00833768
What this trial is testing

A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphataemic Chronic Kidney Disease Patients Not on Dialysis

Who this might be right for
Chronic Kidney DiseaseHyperphosphatemia
Genzyme, a Sanofi Company 5
Large-scale testing (Phase 3)Study completedNCT01074125
What this trial is testing

A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease

Who this might be right for
HyperphosphatemiaEnd-Stage Renal Disease
Keryx Biopharmaceuticals 154
Large-scale testing (Phase 3)Study completedNCT01514851
What this trial is testing

Phase III Double-blind Comparative Study of BAY77-1931 (Lanthanum Carbonate) With Calcium Carbonate

Who this might be right for
Hyperphosphatemia
Bayer 259
Not applicableUnknownNCT05439980
What this trial is testing

Improving Phosphate Control in Children With CKD

Who this might be right for
Chronic Kidney DiseasesHyperphosphatemiaPediatric Kidney Disease+2 more
Great Ormond Street Hospital for Children NHS Foundation Trust 100
Early research (Phase 1)Study completedNCT01976572
What this trial is testing

Drug-Drug Interaction Study to Evaluate the Effect of Colestilan on the Pharmacokinetics of Single Doses of Candesartan Cilexetil in Healthy Subjects

Who this might be right for
HyperphosphatemiaChronic Kidney Disease
Tanabe Pharma Corporation 18
Testing effectiveness (Phase 2)Ended earlyNCT00358722
What this trial is testing

An Evaluation of the Long-term Safety of Magnesium Iron Hydroxycarbonate

Who this might be right for
Chronic Kidney Failure
Ineos Healthcare Limited 44
Not applicableStudy completedNCT00967993
What this trial is testing

Trial of a New Formulation of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease

Who this might be right for
HyperphosphatemiaEnd-stage Renal DiseaseRenal Failure Chronic Requiring Hemodialysis
Keryx Biopharmaceuticals 22
Post-approval studies (Phase 4)Study completedNCT05577507
What this trial is testing

Efficacy and Safety of Cholestyramine in the Management of Hyperphosphatemia in Adult Hemodialysis Patients

Who this might be right for
Chronic Kidney DiseasesHemodialysis ComplicationHyperphosphatemia
Ain Shams University 80
Not applicableStudy completedNCT05897502
What this trial is testing

Explore the Effectors of The Transtheoretical Model on Nutritional Education in Patients on Hemodialysis

Who this might be right for
End-Stage Kidney DiseaseHyperphosphatemia
Liu, Liu-Yin 43
Large-scale testing (Phase 3)Study completedNCT00681941
What this trial is testing

An Open Label Dose Titration of Sevelamer Carbonate Tabs 3 Times a Day in Hyperphosphatemic CKD Patients Not On Dialysis

Who this might be right for
Chronic Kidney DiseaseHyperphosphatemia
Genzyme, a Sanofi Company 49
Post-approval studies (Phase 4)UnknownNCT02237534
What this trial is testing

Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia

Who this might be right for
Renal Insufficiency, ChronicHyperphosphatemiaBone Diseases, Metabolic
Osaka University 60
Testing effectiveness (Phase 2)Study completedNCT00505037
What this trial is testing

ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis

Who this might be right for
HyperphosphatemiaChronic Kidney Disease
Astellas Pharma Inc 156
Next Page